BC SCIENCE
Saved by @Mollyycolllinss

#DDDD $LBPS $LOAC

A thread on the potential near term catalysts behind why I have increased my position in 4d Pharma @4dpharmaplc (LON: #DDDD):

 1) NASDAQ listing. This is the most obvious.

The idea behind this is that the huge pool of capital and institutional interest in the NASDAQ will enable a higher per-share valuation for #DDDD than was achievable in the UK.
Comparators to @4dpharmaplc #DDDD (market capitalisation £150m) on the NASDAQ and their market capitalisation:
Seres Therapeutics: $2.33bn = £1.72bn (has had a successful phase 3 C. difficile trial); from my previous research (below) the chance of #DDDD achieving this at least once is at least 90%.

https://t.co/O8Fd9uuR7f
Kaleido Biosciences: $347m = £256m. 4 products under consideration, compared to #DDDD's potential 16. When you view @4dpharmaplc's 1000+ patents and AI-driven MicroRx platform (not to mention their end-to-end manufacturing capability), 4d's undervaluation is clear.
Evelo Biosciences: $496m = £366m. 11 potential treatments under consideration compared to #DDDD's 16. 4d's IP, platform and manufacturing are superior. Very arguable that 4d should be comparably valued. @lramseu's content is excellent for comparisons.
This does not take into account the recent frenzy for IPOs/SPAC offerings, like #DDDD. In fact, however, without DraftKings and Nikola included, SPAC returns are negative - hence the case for 4d rests firmly on fundamentals.

https://t.co/EHvA8xVbep.
2) Potential Blautix Phase 3 trial. The below graphic taken from @AimHardy's excellent research shows #DDDD's Blautix was comparable to existing IBS-C and D offerings.
It offers a far superior safety profile however, making it the potential treatment of choice, especially for the $1.1bn-$1.65bn IBS-M market (patients whose symptoms fluctuate between IBS-C and D).
The fact that c. 60% of phase 3 trials are a success notwithstanding, comparing Blautix with Seres' C.difficile trial shows how selecting for specific biomarkers/genotype can yield a highly successful final stage trial.
Just the initiation of a trial netted Seres $20m from Nestlé Health Science, excluding the revenues from developing a safe live biotherapeutic. The potential for #DDDD to rerate, just based on precedent (Seres jumped c. 500% on their P3 success) is colossal.
It is likely that the announcement of a phase 3 trial and partner would lead to some of this movement being priced in, given the favourable chance of a success. Hence it is a potential near term (3-6 month) catalyst, and if not, a potential long term catalyst.
3) Potential FDA fast track for MRx0518. Interim analysis for the #DDDD treatment on its own yielded the following (from 17 individuals under trial):
"Following MRx0518 treatment, relative increases in cytotoxic cells, CD8+ T cells and other immune subsets associated with anti-tumor activity were observed in paired tumor samples.
Upregulation of key immuno-stimulatory anti-tumor cytokines and chemokines, such as IL-12 and CXCL10, was observed in post-treatment plasma samples."
Gene expression analysis identified significant expression changes in 98 genes (p<0.05) in paired samples as a result of MRx0518 treatment, including upregulation of pathways associated with antigen presentation, costimulatory signaling, cytokine and chemokine signaling, known
…to promote anti-tumor immune activity."

This is for #DDDD's treatment group who had exhausted many previous options and had metastatic cancer.
The fact that #DDDD's treatment is clearly having an effect without significant side effects is extremely important (as patients may forgo treatment due to side effects alone), and certainly presents the opportunity for fast-track approval.
To me, it belongs in this list of 2020 fast track approvals:

https://t.co/GFsF6ZYraA

This is without taking into account #DDDD's trial of MRx0518 with Merck $MRK's Keytruda, which is likely to yield as high if not greater efficacy than MRx0518 alone.
4) Potential Merck takeover. This is more dubious so can be listed as a fringe point.
#DDDD's bacterial vaccine partnership with Merck yields a potential $347.5m in milestone payments, and if other treatments show further efficacy then, given Merck's interest in the MicroRx platform and live biotherapeutics (they own 6% of 4d) they may well consider a takeover,…
…which typically occur at a substantial premium to the current share price. Takoevers of Rebiotix and Epibiome in recent history offer validation of this theory.
The key here is if #DDDD become attractive enough to be taken over, their share price would have likely enjoyed a substantial re rate from today's levels already.
To summarise, I believe #DDDD offers substantial long-term value. However there are a number of potential near term catalysts, chiefly a NASDAQ listing, which have prompted me to increase my position in the short term from its historical average.
I believe a #DDDD rerate (and a subsequent SP multiplying of 2-3x given 4d have cash till Q4) could well happen in the coming 3-6 months, and I have positioned accordingly.

Merry Christmas and Happy Holidays!

#DDDD $LBPS $LOAC

More from Science

Nick Hudson \U0001f642
Nick Hudson 🙂
@NickHudsonCT
Here is another very enjoyable conversation, with @Pandata19’s scientific advisory board member, Dr Jay Bhattacharya. Key ideas in this thread.

We are making world-changing decisions on the basis of evidence that is not very good. Vast scientific evidence tells us that infection fatality rates are much lower than originally expected. A small fraction of people get severe illness. 2/10

The scientific community has been resistant to evidence not supporting the majoritarian view, preferring instead to gin up panic, focusing on the worst case for everything the virus does & the best case for everything lockdowns do, and ignoring the range of uncertainty. 3/10

Academe is a strange place now, with debate stifled. But there's a sense some are opening up to considering opposing views. This is key, since suppression of views stops knowledge from progressing—the end of science. Public health norms of unified messaging complicate this. 4/10

Why did we, from the start, assume we knew nothing about this virus, instead of assuming a reasonable prior? Low susceptibility was evident early on. Assuming any virus is new is hard to square with our deep-time co-evolution with viruses, & their slow evolution. 5/10
SCIENCE
Dr Amanda Moehring
Dr Amanda Moehring
@FlyBehaviour
In Academia, people aren’t always supported when they need it. I want to share what @WesternU did when my husband died right after the pandemic shutdown. It should be shared with other uni’s as a model for empathy and proactive care when someone is in crisis.
1/
#AcademicChatter
SCIENCE
Advertisement
Sean Carroll
Sean Carroll
@seanmcarroll
Hugh Everett's birthday! Pioneer of the Many-Worlds Interpretation of quantum mechanics. Let us celebrate by thinking about ontological extravagance. I will do so by way of analogy, because I have found that everyone loves analogies and nobody ever willfully misconstrues them.


We look at the night sky and see photons arriving to us, emitted by distant stars. Let's contrast two different theories about how stars emit photons.

One theory says, we know how stars shine, and our equations predict that they emit photons roughly uniformly in all directions. Call this the "Many-Photons Interpretation" (MPI).

But! Others object. That is *so many photons*. Most of which we don't observe, and can't observe, since they're moving away at the speed of light. It's too ontologically extravagant to posit a huge number of unobservable things!

So they suggest a "Photon Collapse Interpretation." According to this theory, the photons emitted toward us actually exist. But photons that would be emitted in directions we will never observe simply collapse into utter non-existence.
SCIENCE
Lior Pachter
Lior Pachter
@lpachter
"The new answer to a 77-year-old problem"

😭


https://t.co/hm9NoaU4nr


https://t.co/8fKDiKjSWc


https://t.co/jkaicC1F2x


https://t.co/PpxWT4Jef4
SCIENCE
Dr. Richard Corsi
Dr. Richard Corsi
@CorsIAQ
1/ Automobiles and Intake Fraction. Since cars are back in the news I thought I would retweet this model result I offered in early April 2020. I focused only on 1 micron particles & accounted for windows completely closed & cracked slightly open.


2/ Related air exchange rates were based on experimental results in literature for mid-sized sedans. Particle deposition to indoor surfaces were accounted for, as the surface to volume ratio in a 3 m3 cab is large. An important outcome was the intake fraction (IF)

3/ Here, IF is the number of particles (or virions in collective particles) inhaled by a receptor DIVIDED BY the number or particles (or virions in collective particles) emitted by an infector.

4/ Integrated over the two hour drive (in this example) the IF for all windows closed & a receptor at rest is 0.08 (8% of what comes out of the infectors respiratory system ends up in the respiratory system of the receptor). 8%! That is a very high intake factor.

5/ With additional ventilation from cracking a window open drops the IF to 0.012 (1.2%) still relatively high. Can get lower by opening more windows.
SCIENCE

You May Also Like

Enigma
Enigma
@ainittomai
On December 25 Mr Pool retweeted August 16 message about the Phoenix and that the worst was still on the horizon to come. 1/*


Maybe now we can assume that November 3 message meant "FUD" nor "FUN". Putting the word in capital letters seems to indicate the aspect the word fud has in our space, FUD. 2/*


Brad started it on December 22 (1/3 posts (Don't say? Sure) = 13 = Plan B). 3/*


And immediately the SEC followed dropping the bomb (1.3 billions (Don't say? Sure) = 13 = Plan B). 4/*


FUD materializes, Bitstamp is one of the first that haltes XRP trading and so on. 5/*
FOR LATER READ
\u0936\u094d\u0930\u0940\u092e\u093e\u0932\u0940 \u0939\u093f\u0924\u0947\u0936 \u0905\u0935\u0938\u094d\u0925\u0940
श्रीमाली हितेश अवस्थी...
@HiteshAwasthi89
#Thread
Benefits of writing SRI RAMA Jayam!!!

Writing Sri Rama Jayam is known as Likitha Japam- Writing Meditation. This gives one a complete sense of surrender to an inner conscience and peace while writing or chanting the mantras.

#Sri_Rama_Jayam #RamaNavami

Cont 👇

You can write this in any language of your choice. It is the connecting chords with the divine and your inner self.

Below are some points that we came across on the benefits :

Cont 👇

1. Vedas tell that as the sun dispels the darkness, the chanting of Rama Nama dispels all evil and obstacles of life. It is a way of liberation and salvation of human suffering.

2. When you think, that all roads are blocked to walk away from day to day problems..

Cont 👇

writing ‘Sri Ram Ram Ram’ gives you the most needed clarity of thoughts to find away out of odd situations.

3. It was told that a calmness engulfs as one indulges in writing the Sri Rama Jayam bringing in more clarity of mind, tolerance & strength to withstand obstacles in life.

4. Devotion of service of life and its varied forms is devotion to God. So there is no right or wrong way of writing this. The very thought and process to write is a connection with god and finds a inner meaning.

Cont 👇
ALL
Advertisement
Reagan Gomez
Reagan Gomez
@ReaganGomez
Black movie goers know which movies are for us and which films aren’t. We really don’t like our stories being made into films that center (and humanize) people that hate us. The filmmakers/studio know that by naming the film “The Green Book”, black movie goers...

...are going to be expecting a story about black people trying to safely navigate the country (real history) and instead will get a white savior film. Like folks went to see Detroit thinking it was about the riots...

Anywhoo, I know Mahershela is fantastic in it. He was the best thing about the trailer. As rich as the history behind the creation of ‘The Green Book’ is/was, as amazing as Dr. Don Shirley’s story is, WHY is this film about a random, racist driver and his family?

This feeds into the ignorant anti-Black American stereotype of “Black Americans don’t have any culture/history/mythology” or whatever. That our stories are still both being used while simultaneously erased in 2018 is wild to me. It’s gonna clean up come award season. 🤦🏾‍♀️

And now, if black filmmakers WANTED to make a film about The Greenbook, guess what it can’t be called🙃. Just like if someone wanted to make a film about the actual Detroit riots, guess what it can’t be called? Then those filmmakers would run into...
CULTURE
meilong
meilong
@meilong15
一个北大毕业的殡葬工自述武汉封城期间的经历，凄惨。这应该才是武汉的真实情景，跟很多人的叙述是吻合的。


https://t.co/QYTO1SYedG
WUHAN FUNERAL WORKERS REPORT
\U0001f1ee\U0001f1f3Sonal \U0001f1ee\U0001f1f3
🇮🇳Sonal 🇮🇳...
@Dharma_Vaarta
Bharat: Advancement of earth’s earliest civilization

Glorious Vedic Architecture and Temple

Architecture in India was an extremely rich form of expression and highly developed science, with a deep heritage of spirituality in it. #FreeHinduTemple


The centre of all architectural development was the temple and temple or Mandir was the earthly home of God, and like the launching pad for the devotee’s consciousness to soar toward the Divine and the spiritual world.


The murti or deity of the Divine would be placed in the temple sanctum, around which all temple activity would revolve.

Such buildings were often elaborately decorated with stone, wood, plaster, etc. and carved or cut to depict the stories from the Puranas or other sacred texts


Temples were always the centre of religious, social and educational activities, practically more so in
ancient times than today.

During a span of more than two thousand years, various dynasties were known for constructing glorious temples,


some of which include the Mauryan, Ashoka, Gupta, Satavahana, Chedi, Chandella, Chalukya, Solanki, Pallava, Shola, Hoysala, Vijayanagar, and others.

Many of these temples remain beautiful architectural wonders today.
ALL , HISTORY